Can you double your money with Sirius Minerals in 2019?

G A Chester reviews recent developments at Sirius Minerals plc (LON:SXX) and the prospects of the share price soaring in 2019.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When I wrote about Sirius Minerals (LSE: SXX) early last September, the shares were trading at 36p. I thought there was a risk the price could crash 50% by the end of the year, and I reluctantly rated the stock a ‘sell’. Reluctantly, because I’d previously been bullish.

The share price hasn’t quite halved, but it’s down 45% at a little under 20p. The question now is whether investors at this level could double their money in 2019. After all, 40p wouldn’t be much above last year’s high.

Optimism

Sirius did a brilliant job to jump through all the planning hoops to get its polyhalite mine in North Yorkshire off the drawing board. Subsequently, the $1.2bn stage-one funding for the first phase of construction was only a little more generous to new investors than I’d anticipated, and I remained bullish on the stock. I particularly liked that management was intent on avoiding any further equity dilution, planning to raise debt of $3bn at stage two to see the project through to production in 2021.

Caution

There were two reasons why I turned bearish on the stock. First, I took a more cautious view of the company’s production, revenue and profit targets. This was due to concerns about the size of the market for its polyhalite product, the price it might command, and the quality of the off-take agreements it had signed. My other concern was that there’d been no swift finalisation of the stage-two funding. I felt the risk was rising that lenders might insist on a dilutive equity fundraising as part of the $3bn package.

Revisions

On 6 September, the spectre of a dilutive equity fundraising suddenly loomed much larger — from another quarter. Sirius announced it had revised its estimate of capital costs. It said it now required stage-two funding of $3.4bn to $3.6bn, but that it wouldn’t be seeking to increase the planned $3bn of borrowings to cover the additional costs.

Then, last week, it announced it had revised the structure of the $3bn borrowings package with which it had been trying to get lenders on board. Its original aim had been two equal tranches of debt, split between commercial banks and the UK government’s Infrastructure and Projects Authority (IPA). However, the deal it’s now trying to get lenders to buy into is a three-stage financing, with cash being released sequentially on the completion of key construction milestones. It’s proposing the first portion as a high-yield bond (analysts reckon $0.5bn to $0.7bn), followed by a tranche of commercial banks debt ($1.5bn), and finally IPA loans ($0.8bn to $0.9bn).

Looking for clarity

After Sirius completed the stage-one funding, there appeared to be a clear, non-dilutive route to production, via what looked a relatively simple stage-two debt raising. However, due to the increase in the capital costs estimate, the company’s failure to secure the borrowings package it contemplated, and no guarantee its revised proposal will win over lenders, there’s now considerable uncertainty.

The ultimate quantum of equity dilution at stage two is unknown, and there’s also a risk of overall higher borrowing costs. Investor sentiment would doubtless improve on the removal of uncertainty, but I’m not convinced any deal will be sufficient to double the share price. As such, I’m minded to avoid the stock, until we have more clarity.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »